Literature DB >> 4009369

Revision of porto-enterostomy in congenital biliary atresia.

Y Hata, J Uchino, Y Kasai.   

Abstract

For the patients with insufficient bile flow following porto-enterostomy for congenital biliary atresia, removal or resection of granulation or scar tissue at the porta hepatis has been performed. Of 11 reoperations, constant bile excretion was obtained in four. Sufficient resection of scar tissue at the porta hepatis was most important for revision of porto-enterostomy. For resection of scar tissue, a special scissors devised by us was used.

Entities:  

Mesh:

Year:  1985        PMID: 4009369     DOI: 10.1016/s0022-3468(85)80105-6

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  5 in total

1.  Reappraise the effect of redo-Kasai for recurrent jaundice following Kasai operation for biliary atresia in the era of liver transplantation.

Authors:  Manuel Mikery Mendoza; Jiun-Hung Chiang; Shin-Yi Lee; Chun-Yu Kao; Jiin-Haur Chuang; Mao-Meng Tiao; Chih-Sung Hsieh
Journal:  Pediatr Surg Int       Date:  2012-09       Impact factor: 1.827

2.  Indication for redo hepatic portoenterostomy for insufficient bile drainage in biliary atresia: re-evaluation in the era of liver transplantation.

Authors:  T Hasegawa; T Kimura; T Sasaki; A Okada; S Mushiake
Journal:  Pediatr Surg Int       Date:  2003-04-03       Impact factor: 1.827

Review 3.  Managing biliary atresia.

Authors:  R Nelson
Journal:  BMJ       Date:  1989-06-03

4.  A long-term experience with biliary atresia. Reassessment of prognostic factors.

Authors:  D U Tagge; E P Tagge; R A Drongowski; K T Oldham; A G Coran
Journal:  Ann Surg       Date:  1991-11       Impact factor: 12.969

Review 5.  Review of redo-Kasai portoenterostomy for biliary atresia in the transition to the liver transplantation era.

Authors:  Wataru Sumida; Hiroo Uchida; Yujiro Tanaka; Takahisa Tainaka; Chiyoe Shirota; Naruhiko Murase; Kazuo Oshima; Ryo Shirotsuki; Kousuke Chiba
Journal:  Nagoya J Med Sci       Date:  2017-08       Impact factor: 1.131

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.